Livzon Pharmaceutical Group repurchases A shares for cancellation

Livzon Pharmaceutical Group announced the repurchase of 74,400 A shares on September 15, 2025, through the Shenzhen Stock Exchange. The repurchases were executed at prices ranging from RMB 40.09 to RMB 40.62 per share, totaling RMB 2,999,912. These shares are intended for cancellation, and as of the end of September 15, 2025, all 74,400 repurchased shares remained outstanding for cancellation.

The repurchases are part of ongoing activities, with prior repurchases dating back to December 25, 2024. On December 25, 2024, 145,700 A shares were repurchased at RMB 37.75, and on December 26, 2024, 145,300 A shares were acquired at RMB 37.84. Earlier in 2025, significant repurchases included 561,400 A shares on January 14 at RMB 35.62, and 558,400 A shares on February 12 and 13 at RMB 35.82 and RMB 35.81, respectively.

The company's total issued A shares as of September 12, 2025, stood at 604,293,313, which remained unchanged after the reported repurchases on September 15, 2025. This indicates that the repurchased shares are still pending cancellation, maintaining the current issued share count.